Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients

Clinical trial NCT04216771 · UNKNOWN

Trial details

NCT number: NCT04216771
Sponsor: Fujian Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

AML in Remission

Start date: 2020-01-01
Primary completion: 2022-05-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.